
HealthMore in Health→
Study suggests regenerative medicine may hinge on timing, not just dose
Key Takeaways
- Two recent studies found that staggered delivery of repair signals improved vessel regeneration.
- The work may explain why some regenerative therapies disappoint in clinical settings.
- Researchers used engineered affibodies to control the timing of growth-factor release.
DE
DT Editorial Team··via medicalxpress.com

